| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 15, 2005
Accepted on March 30, 2006
Huffington Center of Aging, and Departments of Molecular and Cellular Biologyand Medicine, Baylor College of Medicine, Houston, TX 77030
* To whom correspondence should be addressed. E-mail: rsmith{at}bcm.tmc.edu.
Our objective is to determine the neuromodulatory role of ghrelin in the brain. To identify neurons that express the ghrelin receptor (GHS-R) we generated GHS-R-IRES-tauGFP mice by gene targeting. Neurons expressing the GHS-R exhibit green fluorescence and are clearly evident in the hypothalamus, hippocampus, cortex and midbrain. Using immunohistochemistry in combination with GFP fluorescence, we identified neurons that coexpress the dopamine receptor subtype-1 (D1R) and GHS-R. The potential physiological relevance of coexpression of these two receptors and the direct effect of ghrelin on dopamine signaling was investigated in vitro. Activation of GHS-R by ghrelin amplifies dopamine/D1R-induced cAMP accumulation. Intriguingly, amplification involves a switch in G-protein coupling of the GHS-R from G
11/q to G
i/o by a mechanism consistent with agonist dependent formation of GHS-R/D1R heterodimers. Most importantly, these results indicate that ghrelin has the potential to amplify dopamine signaling selectively in neurons that coexpress D1R and GHS-R.
This article has been cited by other articles:
![]() |
R. G. SMITH, Y. SUN, H. JIANG, R. ALBARRAN-ZECKLER, and N. TIMCHENKO Ghrelin Receptor (GHS-R1A) Agonists Show Potential as Interventive Agents during Aging Ann. N.Y. Acad. Sci., November 1, 2007; 1119(1): 147 - 164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |